Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
386M
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
7.28M
-
Shares change
-
-1.5M
-
Total reported value, excl. options
-
$15.9M
-
Value change
-
-$1.22M
-
Put/Call ratio
-
0.04
-
Number of buys
-
13
-
Number of sells
-
-11
-
Price
-
$2.18
Significant Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q2 2020
32 filings reported holding TRIB - Trinity Biotech plc - Class 'A' Ordinary Shares as of Q2 2020.
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.28M shares
of 386M outstanding shares and own 1.89% of the company stock.
Largest 10 shareholders include STONEHILL CAPITAL MANAGEMENT LLC (2.41M shares), HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC (1.67M shares), RENAISSANCE TECHNOLOGIES LLC (1.58M shares), HEARTLAND ADVISORS INC (870K shares), MORGAN STANLEY (191K shares), ACADIAN ASSET MANAGEMENT LLC (171K shares), Invenomic Capital Management LP (135K shares), GOLDMAN SACHS GROUP INC (59.5K shares), Schonfeld Strategic Advisors LLC (34.8K shares), and CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (28.1K shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.